vs

Side-by-side financial comparison of CHEMUNG FINANCIAL CORP (CHMG) and PRO DEX INC (PDEX). Click either name above to swap in a different company.

CHEMUNG FINANCIAL CORP is the larger business by last-quarter revenue ($23.8M vs $18.7M, roughly 1.3× PRO DEX INC). CHEMUNG FINANCIAL CORP runs the higher net margin — 32.5% vs 11.7%, a 20.7% gap on every dollar of revenue. On growth, CHEMUNG FINANCIAL CORP posted the faster year-over-year revenue change (20.3% vs 11.1%). CHEMUNG FINANCIAL CORP produced more free cash flow last quarter ($43.8M vs $3.5M). Over the past eight quarters, PRO DEX INC's revenue compounded faster (14.3% CAGR vs 0.2%).

Chemung Canal Trust Company is a New York State chartered trust company based in Elmira, New York. It was founded as a publicly traded bank in 1833.

Pro Dex Inc is a precision manufacturing enterprise that produces custom machined components, subassemblies and finished products primarily for medical device original equipment manufacturers, as well as clients in the aerospace and industrial sectors, with its core operating market covering North America.

CHMG vs PDEX — Head-to-Head

Bigger by revenue
CHMG
CHMG
1.3× larger
CHMG
$23.8M
$18.7M
PDEX
Growing faster (revenue YoY)
CHMG
CHMG
+9.2% gap
CHMG
20.3%
11.1%
PDEX
Higher net margin
CHMG
CHMG
20.7% more per $
CHMG
32.5%
11.7%
PDEX
More free cash flow
CHMG
CHMG
$40.3M more FCF
CHMG
$43.8M
$3.5M
PDEX
Faster 2-yr revenue CAGR
PDEX
PDEX
Annualised
PDEX
14.3%
0.2%
CHMG

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CHMG
CHMG
PDEX
PDEX
Revenue
$23.8M
$18.7M
Net Profit
$7.7M
$2.2M
Gross Margin
30.8%
Operating Margin
46.1%
17.5%
Net Margin
32.5%
11.7%
Revenue YoY
20.3%
11.1%
Net Profit YoY
30.9%
7.2%
EPS (diluted)
$1.61
$0.66

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHMG
CHMG
PDEX
PDEX
Q4 25
$23.8M
$18.7M
Q3 25
$28.8M
$18.5M
Q2 25
$10.1M
$17.5M
Q1 25
$25.7M
$17.4M
Q4 24
$25.9M
$16.8M
Q3 24
$24.3M
$14.9M
Q2 24
$23.4M
$15.0M
Q1 24
$23.7M
$14.3M
Net Profit
CHMG
CHMG
PDEX
PDEX
Q4 25
$7.7M
$2.2M
Q3 25
$7.8M
$4.7M
Q2 25
$-6.5M
$1.2M
Q1 25
$6.0M
$3.3M
Q4 24
$5.9M
$2.0M
Q3 24
$5.7M
$2.5M
Q2 24
$5.0M
$1.6M
Q1 24
$7.0M
$655.0K
Gross Margin
CHMG
CHMG
PDEX
PDEX
Q4 25
30.8%
Q3 25
29.0%
Q2 25
19.9%
Q1 25
33.3%
Q4 24
30.2%
Q3 24
34.6%
Q2 24
27.2%
Q1 24
28.0%
Operating Margin
CHMG
CHMG
PDEX
PDEX
Q4 25
46.1%
17.5%
Q3 25
35.0%
16.8%
Q2 25
-87.2%
7.7%
Q1 25
29.9%
20.9%
Q4 24
29.0%
16.0%
Q3 24
29.8%
20.2%
Q2 24
26.8%
15.6%
Q1 24
38.3%
15.5%
Net Margin
CHMG
CHMG
PDEX
PDEX
Q4 25
32.5%
11.7%
Q3 25
27.1%
25.3%
Q2 25
-63.9%
6.8%
Q1 25
23.4%
18.8%
Q4 24
29.8%
12.1%
Q3 24
23.5%
16.6%
Q2 24
21.3%
10.6%
Q1 24
29.7%
4.6%
EPS (diluted)
CHMG
CHMG
PDEX
PDEX
Q4 25
$1.61
$0.66
Q3 25
$1.62
$1.40
Q2 25
$-1.35
$0.33
Q1 25
$1.26
$0.98
Q4 24
$1.24
$0.61
Q3 24
$1.19
$0.75
Q2 24
$1.05
$0.44
Q1 24
$1.48
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHMG
CHMG
PDEX
PDEX
Cash + ST InvestmentsLiquidity on hand
$50.1M
$6.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$254.7M
$41.6M
Total Assets
$2.7B
$62.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHMG
CHMG
PDEX
PDEX
Q4 25
$50.1M
$6.1M
Q3 25
$107.6M
$10.1M
Q2 25
$320.1M
$6.8M
Q1 25
$53.4M
$5.5M
Q4 24
$47.0M
$4.7M
Q3 24
$80.4M
$7.8M
Q2 24
$70.2M
$6.8M
Q1 24
$94.9M
$7.8M
Total Debt
CHMG
CHMG
PDEX
PDEX
Q4 25
Q3 25
Q2 25
$99.1M
$15.4M
Q1 25
Q4 24
Q3 24
Q2 24
$12.0M
Q1 24
Stockholders' Equity
CHMG
CHMG
PDEX
PDEX
Q4 25
$254.7M
$41.6M
Q3 25
$245.3M
$41.5M
Q2 25
$235.0M
$36.6M
Q1 25
$228.3M
$35.3M
Q4 24
$215.3M
$31.8M
Q3 24
$220.7M
$30.9M
Q2 24
$201.2M
$30.9M
Q1 24
$197.1M
$30.9M
Total Assets
CHMG
CHMG
PDEX
PDEX
Q4 25
$2.7B
$62.3M
Q3 25
$2.7B
$64.3M
Q2 25
$2.9B
$61.2M
Q1 25
$2.8B
$64.3M
Q4 24
$2.8B
$60.4M
Q3 24
$2.8B
$54.3M
Q2 24
$2.8B
$52.5M
Q1 24
$2.8B
$50.5M
Debt / Equity
CHMG
CHMG
PDEX
PDEX
Q4 25
Q3 25
Q2 25
0.42×
0.42×
Q1 25
Q4 24
Q3 24
Q2 24
0.39×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHMG
CHMG
PDEX
PDEX
Operating Cash FlowLast quarter
$45.5M
$3.6M
Free Cash FlowOCF − Capex
$43.8M
$3.5M
FCF MarginFCF / Revenue
183.7%
18.8%
Capex IntensityCapex / Revenue
7.1%
0.4%
Cash ConversionOCF / Net Profit
5.88×
1.63×
TTM Free Cash FlowTrailing 4 quarters
$71.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHMG
CHMG
PDEX
PDEX
Q4 25
$45.5M
$3.6M
Q3 25
$12.2M
$2.3M
Q2 25
$9.7M
$-173.0K
Q1 25
$7.2M
$754.0K
Q4 24
$29.8M
$-4.2M
Q3 24
$9.2M
$1.9M
Q2 24
$6.5M
$1.0M
Q1 24
$7.9M
$4.1M
Free Cash Flow
CHMG
CHMG
PDEX
PDEX
Q4 25
$43.8M
$3.5M
Q3 25
$11.8M
$2.2M
Q2 25
$9.4M
Q1 25
$6.9M
$574.0K
Q4 24
$26.2M
$-4.7M
Q3 24
$8.6M
$1.5M
Q2 24
$5.5M
Q1 24
$7.9M
$4.0M
FCF Margin
CHMG
CHMG
PDEX
PDEX
Q4 25
183.7%
18.8%
Q3 25
41.1%
11.9%
Q2 25
92.9%
Q1 25
26.7%
3.3%
Q4 24
101.2%
-27.9%
Q3 24
35.2%
9.8%
Q2 24
23.4%
Q1 24
33.1%
27.7%
Capex Intensity
CHMG
CHMG
PDEX
PDEX
Q4 25
7.1%
0.4%
Q3 25
1.4%
0.5%
Q2 25
3.6%
Q1 25
1.3%
1.0%
Q4 24
14.0%
3.2%
Q3 24
2.5%
2.9%
Q2 24
4.4%
Q1 24
0.3%
0.8%
Cash Conversion
CHMG
CHMG
PDEX
PDEX
Q4 25
5.88×
1.63×
Q3 25
1.57×
0.49×
Q2 25
-0.14×
Q1 25
1.19×
0.23×
Q4 24
5.04×
-2.03×
Q3 24
1.60×
0.77×
Q2 24
1.30×
0.66×
Q1 24
1.13×
6.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons